• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow

Psilocybin for major depression granted Breakthrough Therapy by FDA

by EmpathiCSubstanceS | Nov 25, 2019 | Depression

The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD). Back in late...

What Are the Medicinal and Spiritual Benefits of Psilocybin Mushrooms?

by EmpathiCSubstanceS | Nov 25, 2019 | Psychedelic Medicine

Psilocybin cubensis, a psychedelic species of fungi commonly known as “magic mushrooms,” has been part of human culture for thousands of years. Known to both ancient cultures and to modern science as being able to reliably produce a mystical experience, these...

Kicking the Habit: Psilocybin Mushrooms Proven to Help Long-Term Smokers Quit

by EmpathiCSubstanceS | Nov 25, 2019 | Psychedelic Medicine

We’ve come a long way from doctors endorsing cigarettes and authority figures saying that nicotine is perfectly safe, but even in this day and age when we know that tobacco is the single leading cause of preventable death,[1. CDC Tobacco Fact Sheet:...

Can Cannabis Prevent Dyskinesia in Long-Term Treatment of Parkinson’s Disease?

by EmpathiCSubstanceS | Nov 25, 2019 | Parkinson's Disease

In 1970, Oliver Sacks wrote five letters to various medical journals in the U.S. expressing his concern about the prescription drug levodopa, which had been developed just a year earlier. As a practicing neurologist, he had used levodopa (L-Dopa) to treat Parkinson’s...

Ending the Obsession: Psilocybin Found to Effectively Treat Obsessive-Compulsive Disorder

by EmpathiCSubstanceS | Nov 25, 2019 | OCD

Obsessive-compulsive disorder, also known as OCD, is a subversive and hard-to-treat condition that in extreme cases can have bizarre, disruptive, and even life-threatening consequences. You may have heard people refer to small idiosyncrasies as “being OCD,” but the...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

MDMA-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

Aug 11, 2022

In the intent-to-treat set, the active groups had the largest reduction in Clinician-Administered PTSD Scale total scores at the primary endpoint, with mean (standard deviation) changes of −26.3 (29.5) for 125 mg, −24.4 (24.2) for 100 mg, and −11.5 (21.2) for 40 mg,...

A Systematic Study of Microdosing Psychedelics

Aug 11, 2022

Analyses of daily ratings revealed a general increase in reported psychological functioning across all measures on dosing days but limited evidence of residual effects on following days. Analyses of pre and post study measures revealed reductions in reported levels of...

Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

Aug 11, 2022

Results indicated that psilocybin enhanced divergent thinking and emotional empathy the morning after use. Enhancements in convergent thinking, valence-specific emotional empathy, and well-being persisted seven days after use. Sub-acute changes in empathy correlated...

Psychedelic Medicine

It’s Official: DMT Makes You Believe in God

Nov 6, 2020

More than half of users of the “spirit molecule” told researchers they had started to believe in a higher power. A study has found that most people who regularly use the psychedelic drug DMT develop beliefs in a higher power such as God, according to a new study by...

Legal Ayahuasca Churches Are Spreading Across Canada

Nov 6, 2020

A sixth religious group in Canada has been granted an exemption to use the hallucinogenic tea, known for causing visions and vomiting, as part of its ceremonies A church in Winnipeg, Manitoba just became the latest to get a government exemption to legally import and...

MindMed To Evaluate Ayahuasca’s Active Ingredient DMT In Phase 1 Clinical Trial Collaboration

Nov 6, 2020

Phase 1 Trial to experiment with dosing methods to better understand how humans react to DMT, setting stage for future potential Phase 2a proof of concept trials BASEL, Switzerland, June 18, 2020 /PRNewswire/ -- MindMed will now pursue N,N-Dimethyltryptamine (DMT),...

PSYCHEDELICS TODAY

Nov 6, 2020

By Jasmine Virdi As the use of ayahuasca becomes increasingly widespread, the Amazonian vine has extended its roots beyond the traditional indigenous and religious contexts of South America, lending itself to a newly evolving field of practice. However, the economic...

Psychedelics Improve Depression and Wellbeing Scores in Individuals With Eating Disorders

Nov 5, 2020

This study provides the first preliminary quantitative exploration of the psychological effects of psychedelics in individuals with a self-reported diagnosis of an eating disorder.   Introduction According to the National Eating Disorders Association, eating...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow